Compare WENC & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WENC | NRXP |
|---|---|---|
| Founded | N/A | 2015 |
| Country | | United States |
| Employees | N/A | 29 |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.2M | 151.5M |
| IPO Year | 2026 | N/A |
| Metric | WENC | NRXP |
|---|---|---|
| Price | $10.00 | $3.10 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $38.25 |
| AVG Volume (30 Days) | 14.0K | ★ 820.3K |
| Earning Date | N/A | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2,547.84 |
| Revenue Next Year | N/A | $1,591.73 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.89 | $1.65 |
| 52 Week High | $10.00 | $5.06 |
| Indicator | WENC | NRXP |
|---|---|---|
| Relative Strength Index (RSI) | 53.25 | 33.33 |
| Support Level | $9.92 | $2.90 |
| Resistance Level | N/A | $3.36 |
| Average True Range (ATR) | 0.01 | 0.33 |
| MACD | 0.00 | -0.12 |
| Stochastic Oscillator | 37.50 | 0.70 |
West Enclave Merger Corp is a blank check company.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.